chr17-32444540-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002815.4(PSMD11):āc.17T>Cā(p.Val6Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000686 in 1,604,626 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002815.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSMD11 | NM_002815.4 | c.17T>C | p.Val6Ala | missense_variant | 1/14 | ENST00000261712.8 | NP_002806.2 | |
PSMD11 | NM_001270482.2 | c.17T>C | p.Val6Ala | missense_variant | 1/13 | NP_001257411.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSMD11 | ENST00000261712.8 | c.17T>C | p.Val6Ala | missense_variant | 1/14 | 1 | NM_002815.4 | ENSP00000261712.3 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151838Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000866 AC: 2AN: 230994Hom.: 0 AF XY: 0.00000792 AC XY: 1AN XY: 126278
GnomAD4 exome AF: 0.00000688 AC: 10AN: 1452788Hom.: 0 Cov.: 31 AF XY: 0.00000692 AC XY: 5AN XY: 722298
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151838Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74146
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2022 | The c.17T>C (p.V6A) alteration is located in exon 1 (coding exon 1) of the PSMD11 gene. This alteration results from a T to C substitution at nucleotide position 17, causing the valine (V) at amino acid position 6 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at